MARKET

ARGX

ARGX

Argenx Se
NASDAQ
811.45
-8.86
-1.08%
After Hours: 815.00 +3.55 +0.44% 17:29 02/06 EST
OPEN
814.66
PREV CLOSE
820.31
HIGH
832.90
LOW
810.74
VOLUME
375.24K
TURNOVER
--
52 WEEK HIGH
934.62
52 WEEK LOW
510.06
MARKET CAP
49.63B
P/E (TTM)
35.09
1D
5D
1M
3M
1Y
5Y
1D
Morgan Stanley Remains a Buy on Argenx Se (ARGX)
TipRanks · 5d ago
Weekly Report: what happened at ARGX last week (0126-0130)?
Weekly Report · 5d ago
Artisan Global Opportunities Fund Q4 2025 Portfolio Update
Seeking Alpha · 01/29 14:39
Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA), Opus Genetics (IRD) and Argenx Se (ARGX)
TipRanks · 01/27 15:00
Weekly Report: what happened at ARGX last week (0119-0123)?
Weekly Report · 01/26 09:36
Merck added to BofA's best ideas list—see all the names
Seeking Alpha · 01/21 22:33
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Agenus (AGEN) and Assertio Therapeutics (ASRT)
TipRanks · 01/21 15:30
Argenx Se (ARGX) Receives a Buy from Evercore ISI
TipRanks · 01/21 07:45
More
About ARGX
argenx SE, formerly arGEN X BV, is a Netherlands-based biopharmaceutical company. It is primarily engaged in creating and developing a pipeline of differentiated antibody therapeutics for the treatment of severe autoimmune diseases using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes, but is not limited to: Empasiprubart, a complement inhibitor targeting C2, blocking the function of both the classical and lectin pathways, while leaving the alternative pathway intact, ARGX-119 an antagonist to the MuSK receptor with potential in multiple neuromuscular indications.

Webull offers argenx SE - ADR stock information, including NASDAQ: ARGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARGX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ARGX stock methods without spending real money on the virtual paper trading platform.